ConductScience.org, home

Library / Trials

Regional Lung Ventilation During Prone Position in in Intubated Children

NCT07921745, Not applicable, Not yet recruiting, Assistance Publique - Hôpitaux de Paris

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleRegional Lung Ventilation During Prone Position in in Intubated ChildrenClinicalTrials.gov
NCT numberNCT07921745ClinicalTrials.gov
StatusNot yet recruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment30 participants, estimatedClinicalTrials.gov
Lead sponsorAssistance Publique - Hôpitaux de ParisClinicalTrials.gov
ConditionsPediatric Acute Respiratory FailureClinicalTrials.gov
InterventionsThoracic electric impedance tomography to assed regional ventilation, Positive end-expiratory pressure (PEEP) trial titration, Collection of clinical DataClinicalTrials.gov
First posted2026-11-06ClinicalTrials.gov
Last updated2026-11-06ClinicalTrials.gov

Registered outcomes 12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChange in regional lung ventilation distributionBefore and after 1 hour, 6 hours and 16 hours of prone position
Change in regional lung ventilation distribution assessed by thoracic electrical impedance tomography (EIT) (ΔZ) expressed as the percentage change in ΔZ relative to the reference condition (supine position).
ClinicalTrials.gov
SecondaryOptimal positive end-expiratory pressure trial levelBefore and after 1 hour and 16 hours of prone positionOptimal positive end-expiratory pressure trial level.ClinicalTrials.gov
SecondaryRespiratory System ComplianceBefore and after 1 hour, 6 hours and 16 hours of prone positionRespiratory system compliance (Crs) computed as (Pplat-PEEP)/Vt.ClinicalTrials.gov
SecondaryOxygen Saturation Index (OSI)After 1 hour and after 16 hours of prone position
Computed as OSI = (PmxFiO2x100)/SpO2, where Pm is the mean pressure of the respiratory system (collected on the ventilator), FiO2 is the inspired fraction of oxygen, SpO2 is the pulsed oxygen saturation. Patients will be considered as prone position responders if their OSI increases of more than 10% after prone position.
ClinicalTrials.gov
SecondaryNumber of days without ventilation28 days after the first prone positioningData collected from the patient's medical record.ClinicalTrials.gov
SecondaryDeath at 28 days28 days after the first prone positioningData collected from the patient's medical record.ClinicalTrials.gov
SecondaryChange in Regional ComplianceBefore and after 1 hour, 6 hours and 16 hours of prone positioningChange in Regional Compliance assessed by EIT (ΔCreg), expressed as the percentage change in ΔCreg relative to the reference condition (supine position).ClinicalTrials.gov
SecondaryChange in End-Expiratory Lung ImpedanceBefore and after 1 hour, 6 hours and 16 hours of prone positioningChange in End-Expiratory Lung Impedance assessed by EIT (ΔEELI), expressed in arbitrary units (AU), relative to the reference condition (supine position).ClinicalTrials.gov
SecondaryChange in the proportion of tidal ventilation distributed to the dorsal lung regionsBefore and after 1 hour, 6 hours and 16 hours of prone positioningChange in the proportion of tidal ventilation distributed to the dorsal lung regions, calculated as ΔZdorsal/ΔZtotal × 100, relative to the reference condition (supine position).ClinicalTrials.gov
SecondaryChange in the Center of VentilationBefore and after 1 hour, 6 hours and 16 hours of prone positioning
Change in the Center of Ventilation (CoV) assessed by EIT. A CoV of 0.5 indicates a centrally distributed ventilation pattern, whereas values below or above 0.5 indicate predominantly ventral or dorsal ventilation, respectively.
ClinicalTrials.gov
SecondaryChange in the Global InhomogeneityBefore and after 1 hour, 6 hours and 16 hours of prone positioningChange in the Global Inhomogeneity (GI) index assessed by EIT. Lower values indicate a more homogeneous distribution of ventilation, whereas higher values reflect greater ventilation inhomogeneity.ClinicalTrials.gov
SecondaryChange in the percentage of lung regions exhibiting Regional Ventilation DelayBefore and after 1 hour, 6 hours and 16 hours of prone positioningChange in the percentage of lung regions exhibiting Regional Ventilation Delay (RVD), assessed by EIT.ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 10

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
9351620BACKGROUNDPubMed
16014597BACKGROUNDPubMed
23688302BACKGROUNDPubMed
27596161BACKGROUNDPubMed
28328787BACKGROUNDPubMed
31992677BACKGROUNDPubMed
32016593BACKGROUNDPubMed
34898392BACKGROUNDPubMed
36661420BACKGROUNDPubMed
38512400BACKGROUNDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)